Get started
Author

Charlotte Munro

Association Between Increased Dispensing of Opioid Agonist Therapy Take-Home Doses and Opioid Overdose and Treatment Interruption and Discontinuation
2022 · Tara Gomes, Tonya J. Campbell, et al. · JAMA · 92
Synaptic activity regulates AMPA receptor trafficking through different recycling pathways
2015 · Ning Zheng, Okunola Jeyifous, et al. · eLife · 59
Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population‐based propensity‐score matched cohort study
2022 · Tara Gomes, Daniel McCormack, et al. · Addiction · 44
PDF
Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysis
2022 · Sophie A. Kitchen, Tonya J. Campbell, et al. · International Journal of Drug Policy · 31
A qualitative study of a publicly funded pharmacy-dispensed naloxone program
2021 · Tony Antoniou, Cheryl Pritlove, et al. · International Journal of Drug Policy · 23
PDF
Co‐Authoring and Reporting on Lived Experience Engagement in Mental Health and/or Substance Research: A Qualitative Study and Guidance Document
2025 · Natasha Y. Sheikhan, Kerry Kuluski, et al. · Health Expectations · 18
Characteristics, treatment patterns and retention with extended-release subcutaneous buprenorphine for opioid use disorder: A population-based cohort study in Ontario, Canada
2023 · Anita Iacono, Tianru Wang, et al. · Drug and Alcohol Dependence · 18
Impact of the COVID-19 pandemic on the prevalence of opioid agonist therapy discontinuation in Ontario, Canada: A population-based time series analysis
2022 · Ria Garg, Sophie A. Kitchen, et al. · Drug and Alcohol Dependence · 16
PDF
Geographic variation in the provision of naloxone by pharmacies in Ontario, Canada: A population-based small area variation analysis
2020 · Tony Antoniou, Daniel McCormack, et al. · Drug and Alcohol Dependence · 16
PDF
Impact of policy changes on the provision of naloxone by pharmacies in Ontario, Canada: a population‐based time–series analysis
2020 · Tony Antoniou, Diana Martins, et al. · Addiction · 14
PDF
Evaluation of the gap in delivery of opioid agonist therapy among individuals with opioid‐related health problems: a population‐based retrospective cohort study
2022 · Lauren A. Paul, Ahmed M. Bayoumi, et al. · Addiction · 10
Impact of a publicly funded pharmacy-dispensed naloxone program on fatal opioid overdose rates: A population-based study
2022 · Tony Antoniou, Siyu Men, et al. · Drug and Alcohol Dependence · 10
PDF
Opioid Agonist Treatment Retention Among People Initiating Methadone and Buprenorphine Across Diverse Demographic and Geographic Subgroups in Ontario: A Population-based Retrospective Cohort Study
2023 · Abdulrahman Elnagdi, Daniel McCormack, et al. · The Canadian Journal of Addiction · 9
Trends in opioid toxicities among people with and without opioid use disorder and the impact of the COVID-19 pandemic in Ontario, Canada: A population-based analysis
2024 · Shaleesa Ledlie, Mina Tadrous, et al. · International Journal of Drug Policy · 8
Gaps in the Engagement of People With Lived and Living Experience and Caregivers in Mental Health and Substance Use Health Research: A Qualitative Study of Untapped Potential
2025 · Lisa D. Hawke, Jingyi Hou, et al. · Health Expectations · 4
Initiation and Dose of Methadone Monotherapy vs Combination Therapy, 2015 to 2023
2025 · Ria Garg, Jin Luo, et al. · JAMA Network Open · 2
PDF
‘Working Together to Meet in the Middle’. A Qualitative Descriptive Study of Power Dynamics in Lived Experience and Family Engagement in Mental Health and Substance Use Health Research
2026 · Lisa D. Hawke, Joshua Dunphy, et al. · Health Expectations · 1
Association between early methadone dose titration and treatment discontinuation and opioid toxicity: A retrospective cohort study
2026 · Ria Garg, Jin Luo, et al. · PLoS Medicine · 1
PDF
“A sense of community.” A qualitative descriptive study on how to build relationships and rapport with people with lived/living experience and caregivers engaged in mental health and substance use health research
2026 · Diana Kaliza, Wuraola Dada-Phillips, et al. · Social Sciences & Humanities Open · 1
Communicating Effectively when Engaging People with Lived Experience in Mental Health and Substance use Health Research: A Qualitative Descriptive Study
2025 · Lisa D. Hawke, Wuraola Dada-Phillips, et al. · Patient Experience Journal · 1
Patient and Prescriber characteristics associated with return to daily-dispense methadone: A multilevel cohort study
2025 · Ria Garg, Shaleesa Ledlie, et al. · PLOS mental health. · 1
“Inclusivity requires an active effort”: building an inclusive and diverse space when engaging people with lived and living experience and caregivers in mental health and substance use health research
2025 · Abigail Amartey, Shoshana Hauer, et al. · Research Involvement and Engagement · 1
PDF
Initiation of opioid agonist treatment following hospital-treated opioid toxicities and the risk of repeat events in Ontario, Canada: a cohort study using inverse probability of treatment weights
2025 · Shaleesa Ledlie, Mina Tadrous, et al. · BMJ Public Health · 1
PDF
Author response: Synaptic activity regulates AMPA receptor trafficking through different recycling pathways
2015 · Ning Zheng, Okunola Jeyifous, et al. · eLife · 1
Building or Breaking Trust in Healthcare Through Patient and Family Engagement in Research and Service Design: The Need for Authentic Engagement Practices
2026 · Lisa D. Hawke, Hajar Seiyad, et al. · Patient Experience Journal
PDF
Works count: 39
Citation count: 382
H-index: 10
I10-index: 12
Year
Topic
Type